Conformational Flexibility and Crystallization: the Case of Furosemide

Na Tang,Xuemin Wang,Wei Du,Lei Zhang,Jun Xiang,Songbo Wang,Penggao Cheng,Liang Zhu,Qiuxiang Yin

DOI: https://doi.org/10.1021/acs.cgd.8b01407

IF: 4.01

2019-01-01

Crystal Growth & Design

Abstract:The nucleation and growth processes of furosemide crystals in crash-cooling crystallization, evaporative crystallization, and antisolvent crystallization were investigated to evaluate the effects of molecular conformational flexibility on the crystallization process and polymorph formation. Powder X-ray diffraction, thermogravimetric analysis, solid attenuated total reflectance FTIR spectroscopy, and scanning electron microscopy were used to characterize three furosemide polymorphs, one of which was obtained in pure form only once. The relationship among the three forms was determined from both the thermogravimetric analysis data and the solution-mediated polymorphic transformation experiments. It was found that both form II and form III are monotropically related to form I and that form I is the most stable form over the investigated temperature range. Crystallization of furosemide was studied in 10 organic solvents at different temperatures, supersaturatons, and pressures to gain a general view of the polymorphic outcome and the ease of the crystallization. The energy barrier to go from conformer II or III to conformer I in solution is estimated to be about 15 kJ.mol(-1), which is moderate under ambient conditions for the transition, while that to go from conformer II to conformer III is calculated to be around 2 kJ.mol(-1), which indicates that the interconversion between II and III facile. It was found that in solution crystallizations, pure furosemide form I and form II can be obtained, while form III cannot be obtained in pure form; form III can arise concomitantly or together with form I, or the three forms can arise together. The molecular conformational flexibility is not a problem for the polymorphic crystallization of furosemide. Finally, the pathways to produce different polymorphs of furosemide were paved to outline the differences among the conformational polymorphs.